2015 Q2 Form 10-Q Financial Statement

#000156459015006668 Filed on August 07, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2014 Q4
Revenue $1.550M $2.277M
YoY Change -49.15% -20.02%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.600M $5.050M
YoY Change 7.98% 36.12%
% of Gross Profit
Research & Development $19.69M $19.64M
YoY Change -16.71% 61.91%
% of Gross Profit
Depreciation & Amortization $290.0K $380.0K
YoY Change -14.71% 11.76%
% of Gross Profit
Operating Expenses $24.28M $24.69M
YoY Change -12.97% 55.87%
Operating Profit
YoY Change
Interest Expense -$250.0K -$10.00K
YoY Change -516.67% -125.0%
% of Operating Profit
Other Income/Expense, Net -$110.0K $130.0K
YoY Change -600.0% -230.0%
Pretax Income -$23.59M -$22.29M
YoY Change -4.8% 70.67%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$23.59M -$22.29M
YoY Change -4.79% 70.7%
Net Earnings / Revenue -1522.0% -978.74%
Basic Earnings Per Share
Diluted Earnings Per Share -$804.0K -$847.9K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $93.38M $122.7M
YoY Change -39.48% -35.23%
Cash & Equivalents $36.49M $49.51M
Short-Term Investments $56.90M $73.14M
Other Short-Term Assets $3.900M $4.100M
YoY Change -22.0% 192.86%
Inventory
Prepaid Expenses
Receivables $700.0K $700.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $97.90M $127.4M
YoY Change -39.04% -33.76%
LONG-TERM ASSETS
Property, Plant & Equipment $8.900M $7.900M
YoY Change 1.14% -9.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $600.0K $700.0K
YoY Change -60.0% 135.69%
Total Long-Term Assets $11.60M $10.86M
YoY Change -10.08% -11.28%
TOTAL ASSETS
Total Short-Term Assets $97.90M $127.4M
Total Long-Term Assets $11.60M $10.86M
Total Assets $109.5M $138.3M
YoY Change -36.89% -32.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.300M $1.200M
YoY Change 21.05% -36.88%
Accrued Expenses $4.746M $6.317M
YoY Change -59.44% 9.59%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.498M
YoY Change
Total Short-Term Liabilities $22.00M $20.28M
YoY Change 9.0% 25.24%
LONG-TERM LIABILITIES
Long-Term Debt $7.961M $9.559M
YoY Change
Other Long-Term Liabilities $5.000M $1.070M
YoY Change 454.32% 11.11%
Total Long-Term Liabilities $7.961M $10.63M
YoY Change 782.59% 1003.74%
TOTAL LIABILITIES
Total Short-Term Liabilities $22.00M $20.28M
Total Long-Term Liabilities $7.961M $10.63M
Total Liabilities $35.00M $37.81M
YoY Change 53.54% 106.29%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $720.0M $695.1M
YoY Change 273651.33% 0.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $74.50M $100.5M
YoY Change
Total Liabilities & Shareholders Equity $109.5M $138.3M
YoY Change -36.89% -32.41%

Cashflow Statement

Concept 2015 Q2 2014 Q4
OPERATING ACTIVITIES
Net Income -$23.59M -$22.29M
YoY Change -4.79% 70.7%
Depreciation, Depletion And Amortization $290.0K $380.0K
YoY Change -14.71% 11.76%
Cash From Operating Activities -$23.57M -$16.87M
YoY Change 4.29% 42.48%
INVESTING ACTIVITIES
Capital Expenditures -$1.050M -$460.0K
YoY Change 101.92% 48.39%
Acquisitions
YoY Change
Other Investing Activities $25.83M $37.57M
YoY Change 92.62% -136.74%
Cash From Investing Activities $24.78M $37.11M
YoY Change 92.24% -136.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.51M 9.760M
YoY Change 205000.0% -92.21%
NET CHANGE
Cash From Operating Activities -23.57M -16.87M
Cash From Investing Activities 24.78M 37.11M
Cash From Financing Activities 20.51M 9.760M
Net Change In Cash 21.72M 30.00M
YoY Change -323.92% 175.74%
FREE CASH FLOW
Cash From Operating Activities -$23.57M -$16.87M
Capital Expenditures -$1.050M -$460.0K
Free Cash Flow -$22.52M -$16.41M
YoY Change 1.99% 42.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
56895000
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
9559000
us-gaap License And Services Revenue
LicenseAndServicesRevenue
10000
us-gaap Revenues
Revenues
6546000
CY2014Q2 us-gaap Business Exit Costs1
BusinessExitCosts1
178000
us-gaap Business Exit Costs1
BusinessExitCosts1
255000
us-gaap Operating Income Loss
OperatingIncomeLoss
-38821000
us-gaap Investment Income Interest
InvestmentIncomeInterest
120000
CY2015Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1498000
CY2014Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
73141000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-23591000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
237000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
228000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-23363000
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
719966000
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
26307000
CY2014Q4 us-gaap Liabilities
Liabilities
37808000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
695058000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
26307000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1070000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
69500000
CY2015Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
7961000
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6317000
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4746000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
10000
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2015Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
93381000
CY2015Q2 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
7000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
109000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
103000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-230000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-13025000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
634000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
24000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-314000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-500000
dvax Accretion Of Debt Discounts Related To Debt Financing
AccretionOfDebtDiscountsRelatedToDebtFinancing
100000
dvax Accretion Of End Of Term Payment Related To Debt Financing
AccretionOfEndOfTermPaymentRelatedToDebtFinancing
107000
dvax Cash Settled Portion Of Stock Based Compensation Expense
CashSettledPortionOfStockBasedCompensationExpense
387000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-200000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3603000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
648000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-2634000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
3217000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1401000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-47711000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-33782000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
18654000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
34585000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1668000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
14263000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
27624000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20213000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
228000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
20653000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
83000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23122000
us-gaap Interest Paid
InterestPaid
433000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
122651000
CY2015Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
93381000
CY2011 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
3000000
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make informed estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates.</p></div>
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
ten-for-one
dvax Reverse Stock Split Effective Date
ReverseStockSplitEffectiveDate
2014-11-07
CY2015Q2 us-gaap Fair Value Equity Level1 To Level2 Transfers Amount
FairValueEquityLevel1ToLevel2TransfersAmount
0
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2015Q2 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
56895000
CY2015Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
500000
CY2014Q2 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
400000
CY2015Q2 us-gaap Deferred Rent Credit
DeferredRentCredit
500000
CY2014Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
600000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
23.27
CY2015Q2 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
22.92
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
12300000
CY2014Q4 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
8000000
CY2014Q1 us-gaap Revenue Recognition Milestone Method Revenue Recognized
RevenueRecognitionMilestoneMethodRevenueRecognized
5400000
dvax Advance Payment On Loan Agreement
AdvancePaymentOnLoanAgreement
40000000
us-gaap Debt Issuance Costs
DebtIssuanceCosts
400000
CY2015Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
11910000
CY2015Q2 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
496000
CY2015Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Years Two And Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearsTwoAndThree
8753000
CY2015Q2 us-gaap Longterm Debt And Capital Lease Obligations Maturities Repayments Of Principal In Years Four And Five
LongtermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearsFourAndFive
2661000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4660000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7630000
CY2015Q2 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2014Q2 us-gaap Dilutive Securities
DilutiveSecurities
0
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
0
CY2015Q2 dvax Number Of Warrants Exercised During Period
NumberOfWarrantsExercisedDuringPeriod
1060000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1820000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1094000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
8000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2723000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2568000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1166000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.83
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
15.60
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.61
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M23D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M21D
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
12303000
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
11323000
CY2015Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
3001000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1918000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1676000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3872000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2946000
CY2014Q4 dvax Share Based Compensation Arrangement By Share Based Payment Award Options And Equity Instruments Other Than Options Nonvested Weighted Average Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedWeightedAveragePrice
27.48

Files In Submission

Name View Source Status
0001564590-15-006668-index-headers.html Edgar Link pending
0001564590-15-006668-index.html Edgar Link pending
0001564590-15-006668.txt Edgar Link pending
0001564590-15-006668-xbrl.zip Edgar Link pending
dvax-10q_20150630.htm Edgar Link pending
dvax-20150630.xml Edgar Link completed
dvax-20150630.xsd Edgar Link pending
dvax-20150630_cal.xml Edgar Link unprocessable
dvax-20150630_def.xml Edgar Link unprocessable
dvax-20150630_lab.xml Edgar Link unprocessable
dvax-20150630_pre.xml Edgar Link unprocessable
dvax-ex311_8.htm Edgar Link pending
dvax-ex312_9.htm Edgar Link pending
dvax-ex321_6.htm Edgar Link pending
dvax-ex322_7.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending